Provided by Tiger Trade Technology Pte. Ltd.

Alvotech

5.67
-0.1800-3.08%
Pre-market: 5.740.0700+1.23%08:32 EDT
Volume:668.88K
Turnover:3.81M
Market Cap:2.02B
PE:-9.32
High:5.83
Open:5.83
Low:5.61
Close:5.85
52wk High:9.05
52wk Low:2.94
Shares:357.00M
Float Shares:141.00M
Volume Ratio:0.48
T/O Rate:0.47%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6081
EPS(LYR):0.0964
ROE:--
ROA:2.19%
PB:-10.57
PE(LYR):58.84

Loading ...

Alvotech, Lotte Biologics announce long-term manufacturing partnership

TIPRANKS
·
Oct 07

Alvotech and LOTTE Biologics announce US-based manufacturing agreement to increase global supply

GlobeNewswire
·
Oct 07

Alvotech and Lotte Biologics Announce US-Based Manufacturing Agreement to Increase Global Supply

THOMSON REUTERS
·
Oct 07

Alvotech - Lotte Biologics to Manufacture Multiple Biosimilars at Syracuse Facility for Global Supply

THOMSON REUTERS
·
Oct 07

Alvotech Partners with LOTTE Biologics for New York Biosimilar Manufacturing Supply

Reuters
·
Oct 07

Manufacturing Approval Could Change The Case For Alvotech (ALVO) Stock

Simply Wall St.
·
Oct 06

Alvotech Gets US FDA Approval For Additional Manufacturing Capacity For Simlandi Biosimilar; Shares Up Pre-Bell

MT Newswires Live
·
Oct 05

FDA Clears Alvotech to Make Simlandi Drug Substance in Second Reykjavik Suite for US Supply

Reuters
·
Oct 05

FDA Approves Additional U.S. Manufacturing Capacity for Simlandi®, Alvotech’s Biosimilar to Humira®

THOMSON REUTERS
·
Oct 05

FDA approves additional U.S. manufacturing capacity for SIMLANDI®, Alvotech’s biosimilar to Humira®

GlobeNewswire
·
Oct 05

Alvotech Swings to USD 65.79 Million Loss for Six Months Ended June 30, 2026; Revenue Falls 31% to USD 211.64 Million

Reuters
·
Sep 29

Alvotech Shares Rise After Double Upgrade From Barclays

MT Newswires Live
·
Sep 17

Alvotech Price Target Raised to $8.00/Share from $4.00 by Barclays

Dow Jones
·
Sep 16

Alvotech : Barclays Raises to Overweight from Underweight

THOMSON REUTERS
·
Sep 16

Alvotech upgraded to Overweight from Underweight at Barclays

TIPRANKS
·
Sep 16

Positive Report for Alvotech (ALVO) from Barclays

TIPRANKS
·
Sep 16

Regeneron Pharmaceuticals More Likely to Retain Eylea HD Patent, RBC Says

MT Newswires Live
·
Sep 10

Sector Update: Healthcare Stocks Decline Monday Afternoon

MT Newswires Live
·
Sep 01

Alvotech Stock Gains After FDA Accepts for Review Crohn's Treatment AVT80

Dow Jones
·
Sep 01

Alvotech Says FDA Accepts AVT80 Biosimilar Application for Review

Reuters
·
Aug 31